NCT04565327 Hyperpolarized 13C Pyruvate MRI for Treatment Response Assessment in Pancreatic Ductal Adenocarcinoma Status TERMINATED Phase PHASE2
NCT04483726 Distal Pancreatectomy, Minimally Invasive or Open, for Malignancy (DIPLOMA) Status UNKNOWN Phase NA
NCT04477343 A Study to Evaluate the Safety and Tolerability of SX-682 in Combination With Nivolumab as a Maintenance Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma Status RECRUITING Phase PHASE1
NCT04469556 Pancreatic Adenocarcinoma Signature Stratification for Treatment Status COMPLETED Phase PHASE2
NCT04449406 Early Detection of Pancreatic Adenocarcinoma (PDAC) Using a Panel of Biomarkers Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04406831 The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer Status RECRUITING Phase N/A
NCT04400903 Monitoring Heart Rate Variability for the Early Detection of Pancreatic Cancer Status TERMINATED Phase N/A
NCT04262388 A Multi-Cancer, Multi-State, Platform Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Pancreatic Adenocarcinoma, Non-Small Cell Lung Cancer and Squamous Cell Carcinoma of the Head and Neck to Correlate Clinical, Molecular and Immunologic Parameters With DNA Methylation Status WITHDRAWN Phase PHASE2
NCT04257448 Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT04211948 Clinical Study Between Robotic and Open Surgery in Patients With Pancreatic Cancer Status UNKNOWN Phase NA
NCT04189393 Microbiome Analysis in esoPhageal, PancreatIc and Colorectal CaNcer Patients Undergoing Gastrointestinal Surgery Status UNKNOWN Phase N/A
NCT04164992 Endoscopic Ultrasound Radiofrequency Ablation (EUS-RFA) of Not-resectable Pancreatic Cancer Status UNKNOWN Phase NA
NCT04150042 SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells Status RECRUITING Phase PHASE1
NCT04146298 Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT04134468 MRI Effects of Pegvorhyaluronidase Alfa (PEGPH20) in Pancreatic Ductal Adenocarcinoma Status WITHDRAWN Phase PHASE2
NCT04115527 Should a Standard Lymphadenectomy Include the No. 16 Lymph Nodes for Patients With Pancreatic Head Adenocarcinoma. Status ACTIVE_NOT_RECRUITING Phase NA